Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details)

v3.24.1.1.u2
Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 18,191,121 18,151,247
Stock Options    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 1,479,059 1,714,298
Unvested Restricted Stock Units    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 2,569,764 2,294,651
Warrants    
Anti-dilutive securities    
Total shares excluded from diluted net loss per share applicable to common stockholders 14,142,298 14,142,298